Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?-Reference-Cited by-同舟云学术

Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?

Published:2013-08 Issue:2 Volume:81 Page:231-234
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Yavas Guler,Elsurer Rengin,Yavas Cagdas,Elsurer Cagdas,Ata Ozlem

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. HER2/neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer;Benz;Oncogene,1997

2. Trastuzumab and doxorubicin related cardiotoxicity and the cardioprotective role of exercise;Wonders;Integr Cancer Ther,2009

3. Node negative breast cancers with p53 (-)/HER2-neu status may identify women with very good prognosis;Albanell;Anticancer Res,1996

4. Trastuzumab plus adjuvant chemotherapy for operable HER-2 positive breast cancer;Romond;N Engl J Med,2005

5. Perez E.A., Suman V.J., Davidson N. et al. NCCTG N9831, May 2005 update Presented at the 45th annual meeting of the American Society of Clinical Oncology Orlando FL, May 16, 2005.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology;International Journal of Molecular Sciences;2022-09-13

2. Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review;International Journal of Medical Toxicology and Forensic Medicine;2022-03-01

3. CardioOncology;Sex Differences in Cardiac Diseases;2021

4. Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician;Clinical Medicine Insights: Cardiology;2019-01

5. Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I;Systemic Hypertension;2017-12-15